Karyopharm Presents Positive Phase 1/2 Eltanexor Data at the American Society of Hematology 2017 Annual Meeting

Go back to Karyopharm Presents Positive Phase 1/2 Eltanexor Data at the American Society of Hematology 2017 Annual Meeting
KARYOPHARM THERAP (NASDAQ: KPTI) Delayed: 0.40 +0.04 (11.11%)
Previous Close $0.36    52 Week High $19.41 
Open $0.36    52 Week Low $4.83 
Day High $0.42    P/E N/A 
Day Low $0.36    EPS $-2.74 
Volume 1,060,641